This test is based on biochip technology to evaluate the risk of 29 high-incidence cancers from the perspective of genetics, and provide guidance to disease prevention.
Glioma, meningioma, nasopharyngeal cancer, oral cancer, laryngeal cancer, lung cancer, thyroid cancer, esophageal cancer, stomach cancer, colorectal cancer, liver cancer, pancreatic cancer, gallbladder cancer, cholangiocarcinoma, osteosarcoma, multiple myeloma, skin cancer, bladder cancer, kidney cancer, prostate cancer, testicular germ cell cancer, breast cancer, cervical cancer, endometrial cancer, ovarian cancer, acute lymphoblastic leukemia, acute myeloid leukemia, chronic myelogenous leukemia, non-Hodgkin's lymphoma.
86-10-69002900